Vuong LG - Search Results

1

Gross S, Ihlow J, Busack L, Adamiak K, Schrezenmeier J, Jesse J, Schwarz M, Flörcken A, Vuong LG, Rieger K, Krönke J, le Coutre P, Boldt V, von Brünneck AC, Horst D, Burmeister T, Blau IW, Keller U, Bullinger L, Westermann J. Gross S, et al. Among authors: vuong lg. Blood Cancer J. 2024 Sep 16;14(1):160. doi: 10.1038/s41408-024-01140-5. Blood Cancer J. 2024. PMID: 39284846 Free PMC article.

2

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.

Hemmati PG, Terwey TH, Massenkeil G, le Coutre P, Vuong LG, Neuburger S, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Int J Hematol. 2010 Apr;91(3):436-45. doi: 10.1007/s12185-010-0515-y. Epub 2010 Feb 25. Int J Hematol. 2010. PMID: 20180052

3

Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.

Vuong LG, Hemmati PG, Neuburger S, Terwey TH, Vulliamy T, Dokal I, le Coutre P, Dörken B, Arnold R. Vuong LG, et al. Acta Haematol. 2010;124(4):200-3. doi: 10.1159/000318721. Epub 2010 Nov 2. Acta Haematol. 2010. PMID: 21042011

4

A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.

Hemmati PG, Terwey TH, le Coutre P, Vuong LG, Massenkeil G, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Eur J Haematol. 2011 Apr;86(4):305-16. doi: 10.1111/j.1600-0609.2011.01580.x. Eur J Haematol. 2011. PMID: 21265883

5

Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.

Hemmati PG, Schulze-Luckow A, Terwey TH, le Coutre P, Vuong LG, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Eur J Haematol. 2014 Feb;92(2):102-10. doi: 10.1111/ejh.12216. Epub 2013 Nov 21. Eur J Haematol. 2014. PMID: 24138573

6

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.

Hemmati PG, Terwey TH, Na IK, le Coutre P, Jehn CF, Vuong LG, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Eur J Haematol. 2015 May;94(5):431-8. doi: 10.1111/ejh.12449. Epub 2014 Oct 11. Eur J Haematol. 2015. PMID: 25220715

7

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.

Hemmati PG, Terwey TH, Na IK, Jehn CF, le Coutre P, Vuong LG, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Eur J Haematol. 2015 Dec;95(6):498-506. doi: 10.1111/ejh.12522. Epub 2015 Mar 24. Eur J Haematol. 2015. PMID: 25598394

8

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.

Hemmati PG, Vuong LG, Terwey TH, Jehn CF, le Coutre P, Penack O, Na IK, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Eur J Haematol. 2017 Feb;98(2):160-168. doi: 10.1111/ejh.12815. Epub 2016 Oct 22. Eur J Haematol. 2017. PMID: 27706846

9

Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.

Hemmati PG, Pfeifer K, Vuong LG, Jehn CF, Terwey TH, le Coutre P, Dörken B, Arnold R. Hemmati PG, et al. Among authors: vuong lg. Bone Marrow Transplant. 2018 Jan;53(1):101-103. doi: 10.1038/bmt.2017.215. Epub 2017 Oct 9. Bone Marrow Transplant. 2018. PMID: 28991253 No abstract available.

10

Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach.

Wittenbecher F, Lesch S, Kolling S, Blau IW, Vuong L, Borchert F, Movasshagi K, Tietze-Bürger C, Penack O, Ahn J, Bullinger L, Frentsch M, Na IK. Wittenbecher F, et al. Front Immunol. 2022 May 23;13:874499. doi: 10.3389/fimmu.2022.874499. eCollection 2022. Front Immunol. 2022. PMID: 35677053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters